PharmD
Signal
Deep dives, evidence grades, and clinical tools, all in one place.
Home
Library
Evidence Rounds
Reference
Guidelines
FDA Alerts
Saved
About
Log In
Subscribe
My Account ▾
Topic Preferences
Email Preferences
Subscription & Billing
Log Out
Subscribe
Recall
FDA MedWatch
Fresenius Kabi Recalls One Lot of Tyenne (tocilizumab-aazg) for Glass Particles
Topic:
Medication Safety / Pharmacovigilance
Published:
Aug 11, 2026
Source:
FDA.gov
🔗 View original FDA notice →
🎓
Reviewed by a licensed pharmacist
Action items and clinical context verified before publication.
← All FDA Alerts
·
Share on LinkedIn
·
Copy link